| Literature DB >> 22520595 |
Nawal M Al-Musayeib1, Ramzi A Mothana, An Matheeussen, Paul Cos, Louis Maes.
Abstract
BACKGROUND: Worldwide particularly in developing countries, a large proportion of the population is at risk for tropical parasitic diseases. Several medicinal plants are still used traditionally against protozoal infections in Yemen and Saudi Arabia. Thus the present study investigated the in vitro antiprotozoal activity of twenty-five plants collected from the Arabian Peninsula.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22520595 PMCID: PMC3493369 DOI: 10.1186/1472-6882-12-49
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
List of plants screened and their traditional uses
| Mo-I10a | Labiatae | L, F | As antiseptic and for teeth pains, stimulant, diuretic and in treatment of rheumatism, gout, palsy, amenorrhea and malaria a,b | |
| Mo-H02a | Asclepiadaceae | L | For diabetes, stomachic ulcer and smallpox a, c | |
| Mo-S11a | Asteraceae | L, T | For wounds and kidney diseases a | |
| Mo-S02a | Euphorbiacea | L, S | As antiseptic for wounds, antimicrobial, cathartic, emetic and hypoglycemic and for hemorrhoids a, d | |
| Mo-S05a | Zingiberaceae | R | For cancers a | |
| Mo-S25a | Cupressaceae | L | As expectorant, astringent and for wounds, diarrhea, hemorrhoids a, c | |
| Mo-T01a | Sapindaceae | L, S | For malaria, wounds and burns, gout , rheumatism and as anesthetic, laxative and tonic a, c, e, f, | |
| Mo-T09 | Moraceae | L, S | For the treatment of fungal and skin diseases a, c | |
| Mo-I06a | Gentianaceae | L | For diabetes a | |
| 15133 | Moraceae | L, S | For the treatment of filariasis, diarrheal infections, tuberculosis and oral infections a, c | |
| 15187 | Moraceae | L, S | For Piles, diarrhea, and as diuretic a | |
| 15163 | Moraceae | L, S | For constipation and lungs and bladder diseases a, c | |
| Mo-S07a | Tiliaceae | L, S | As Diuretic and haemostatic and for kidney diseases a | |
| Mo-I02a | Iridaceae | R | For rheumatism and gout a | |
| Mo-I19a | Asclepiadaceae | L, T | For tumors, skin diseases, scabies and itching a, c, h | |
| Mo-I10a | Liliaceae | R | For malaria a | |
| Mo-I11a | Labiatae | L, F | For wounds, rheumatism, urine retention, and kidney stones and as antiseptic a, d | |
| Mo-I05a | Labiatae | L, F | For kidney diseases and tooth ache a | |
| Mo-M05a | Asteraceae | L, F | For wounds and as antiseptic a | |
| 15732a | Labiatae | L, S | For stomachache, nausea, gastritis, intestinal spasms, burns, wounds, sores, insect bites, allergies, ringworms, infections, malaria and break fevers a, f | |
| Mo-T22a | Anacardiaceae | L | General tonic and for painful joints a | |
| YT-20a | Asteraceae | L, S | As antimicrobial, anthelmintic, diuretic, and antispasmodic agent a, f | |
| Mo-S15a | Asteraceae | L, T | For wounds and for urinary tract infections a | |
| Mo-S17a | Labiatae | L, F | For kidney diseases, rheumatism and diabetes a, d | |
| Mo-T16a | Asteraceae | L, F | For cough, colic and skin diseases a, h |
F Flower, L Leaves, R Roots or rhizomes, S Stems, T Fruits.
a information has been taken from native people.
b Chandel S, Bagai U, 2010 [7].
c Al-Dubai and Al-Khulaidi (1996) [8].
d Atiqur-Rahman et al., (2004) [9].
e Mossa et al., (1987) [10].
f Ali et al., (2004) [11].
g Fleurentin and Pelt (1982) [12].
h Schopen (1983) [13].
Antiprotozoal activity of the methanol extracts of the investigated plants and their cytotoxicity against MRC-5 cell lines
| | | | | ||||||
|---|---|---|---|---|---|---|---|---|---|
| >64.0 | >1 | >64.0 | >1 | 28.8 ± 4.6 | >2.22 | 31.2 ± 5.2 | >2.05 | >64.0 | |
| 27.5 ± 4.3 | >2.33 | >64.0 | >1 | >64.0 | >1 | 32.5 ± 6.5 | >1.97 | >64.0 | |
| 48.2 ± 9.8 | | 32.5 ± 3.5 | | 31.0 ± 6.1 | | 9.1 ± 1.8 | 1.76 | 16.0 ± 5.3 | |
| 5.0 ± 1.2 | 12.80 | 27.3 ± 2.8 | 2.34 | 32.0 ± 5.8 | >2 | 10.8 ± 2.4 | 5.93 | >64.0 | |
| >64.0 | | 27.3 ± 3.1 | 1.41 | 13.8 ± 2.1 | 2.79 | 30.0 ± 4.9 | 1.28 | 38.5 ± 8.2 | |
| 7.6 ± 2.4 | 1.41 | 2.0 ± 0.4 | 5.35 | 8.3 ± 1.9 | 1.29 | 2.1 ± 0.2 | 5.10 | 10.7 ± 3.1 | |
| 34.2 ± 8.7 | 1.44 | >64.0 | | 29.6 ± 3.9 | 1.67 | 22.6 ± 5.8 | 2.19 | 49.4 ± 9.1 | |
| 46.7 ± 11.8 | >1.37 | 45.3 ± 11.8 | 1.41 | >64.0 | >1 | 11.1 ± 1.8 | 5.77 | >64.0 | |
| >64.0 ± | >1 | >64.0 | >1 | >64.0 | >1 | 9.9 ± 1.1 | >6.46 | >64.0 | |
| 27.0 ± 6.9 | 1.20 | 27.3 ± 6.1 | 1.19 | 26.3 ± 3.2 | 1.24 | 8.2 ± 1.9 | 3.96 | 32.5 ± 7.3 | |
| 8.4 ± 2.3 | 3.87 | 32.5 ± 7.2 | 1.00 | 31.2 ± 4.3 | 1.04 | 8.0 ± 2.2 | 4.06 | 32.5 ± 7.5 | |
| 14.5 ± 3.8 | 2.60 | >64.0 | | 22.6 ± 4.0 | 1.67 | 8.1 ± 2.6 | 4.65 | 37.7 ± 6.9 | |
| 11.7 ± 3.5 | 2.32 | 24.1 ± 3.8 | 1.13 | 8.2 ± 1.8 | 3.32 | 2.6 ± 0.9 | 10.46 | 27.2 ± 6.1 | |
| 55.5 ± 6.2 | >1.15 | >64.0 | >1 | >64.0 | >1 | 10.6 ± 3.1 | >6.04 | >64.0 | |
| 27.9 ± 4.9 | | >64.0 | | 0.4 ± 0.2 | 2.00 | 9.6 ± 3.0 | | 0.8 ± 0.2 | |
| 1.3 ± 0.6 | 5.69 | 32.5 ± 4.9 | | 31.4 ± 3.4 | | 5.9 ± 2.8 | 1.25 | 7.4 ± 1.4 | |
| 7.1 ± 1.4 | 4.17 | 20.3 ± 3.5 | 1.46 | 7.9 ± 0.5 | 3.75 | 3.0 ± 1.8 | 9.87 | 29.6 ± 5.9 | |
| 44.6 ± 6.3 | | >64.0 | | >64.0 | | 8.4 ± 2.2 | 3.51 | 29.5 ± 6.0 | |
| 6.5 ± 2.0 | 5.06 | 24.1 ± 2.9 | 1.37 | 23.3 ± 2.9 | 1.41 | 2.6 ± 1.8 | 12.65 | 32.9 ± 6.8 | |
| 21.6 ± 3.8 | >2.96 | 45.3 ± 8.3 | 1.41 | 31.7 ± 4.0 | >2.02 | 7.8 ± 2.1 | >8.21 | >64.0 | |
| 37.1 ± 4.9 | 1.43 | >64.0 | | 30.5 ± 3.9 | 1.74 | 34.0 ± 5.8 | 1.56 | 53.2 ± 7.2 | |
| 14.0 ± 2.8 | 4.57 | 30.1 ± 4.6 | >2.13 | 9.2 ± 1.9 | >6.96 | 2.2 ± 1.5 | >29.09 | >64.0 | |
| >64.0 | >1 | >64.0 | >1 | >64.0 | >1 | >64.0 | >1 | >64.0 | |
| 12.5 ± 2.6 | 2.18 | 32.5 ± 6.6 | | 30.5 ± 2.9 | | 7.1 ± 2.3 | 3.83 | 27.2 ± 5.3 | |
| 41.9 ± 7.9 | | 27.3 ± 5.1 | 1.10 | 9.2 ± 1.2 | 3.27 | 8.0 ± 2.9 | 3.76 | 30.1 ± 4.9 | |
| Chloroquine | 0.3 ± 0.1 | | - | | - | | - | | - |
| Miltefosine | - | | 3.32 ± 0.7 | | - | | - | | - |
| Benznidazole | - | | - | | 2.2 ± 0.5 | | - | | - |
| Suramin | - | | - | | - | | 0.03 ± 0.02 | | - |
| Tamoxifen | - | - | - | - | 11.0 ± 2.3 |
IC50 values of reference drugs are expressed in μM/ml concentrations.